Massachusetts General Hospital Psychopharmacology and Neurotherapeutics
Hardcover

ISBN:
9780323357647
Copyright:
2016
Page Count:
256
Imprint:
Elsevier
List Price:
$79.99
Was
$79.99
Now
$63.99
Free Shipping!
In Stock
This item has low stock levels and may be back-ordered. We'll let you know if it is back-ordered, and
you will not be charged until the item ships.
Put today's best approaches to work for your patients with this practical guide to cutting-edge psychopharmacologic and somatic treatments for psychiatric and neurologic conditions. Comprised of key chapters from the second edition of Stern et al.’s Massachusetts General Hospital Comprehensive Clinical Psychiatry, this user-friendly resource focuses on current psychotropic treatments, electroconvulsive therapy, and neurotherapeutics, making it an ideal quick reference for psychiatrists, psychologists, internists, and nurse practitioners.
-
- Stay current with hot topics in the field, including the use of antiepileptic drugs in psychiatry, ADHD medications, and often-overlooked areas such as treatment of pain.
- Includes detailed coverage of antidepressants, antipsychotics, antianxiety medications, as well as drug–drug interactions, side-effects, and treatment adherence.
- Quickly find the information you need with a user-friendly, highly templated format that features abundant boxed summaries, bulleted points, case histories, algorithms, references, and suggested readings.
- Test your knowledge of psychopharmacology and neurotherapeutics with interactive, downloadable multiple-choice questions with detailed answers for each chapter.
- Benefit from the authoritative content of the parent text, MGH Comprehensive Clinical Psychiatry, 2nd Edition, now featuring new art, new tables, and key points, and updated to DSM-5 where relevant.
-
Theodore A. Stern, MD, Chief, Avery D. Wiesman Psychiatry Consultation Service, Massachusetts General Hospital, Director, Office for Clinician Careers, Massachusetts General Hospital, Ned H. Cassem Professor of Psychiatry in the Field of Psychosomatic Medicine/Consultation, Harvard Medical School, Boston, MA, Maurizio Fava, MD, Director, Clinical Research Program
Executive Vice-Chair, Department of Psychiatry
Executive Director, Clinical Trials Network and Institute
Massachusetts General Hospital
Slater Family Professor of Psychiatry
Harvard Medical School
Boston, MA, Timothy E. Wilens, MD, Senior Staff, Child Psychiatry and Pediatric Psychopharmacology
Director of the Center for Addiction Medicine
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
Boston, MA and Jerrold F. Rosenbaum, MD, Psychiatrist-in-Chief, Massachusetts General Hospital
Chair, Executive Committee on Research
Massachusetts General Hospital
Stanley Cobb Professor of Psychiatry
Harvard Medical School
Boston, MA